vs
Side-by-side financial comparison of Arlo Technologies, Inc. (ARLO) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.
iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $141.3M, roughly 1.5× Arlo Technologies, Inc.). Arlo Technologies, Inc. runs the higher net margin — 4.1% vs 2.7%, a 1.4% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 16.2%). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 6.7%).
Arlo Technologies is an American company that makes wireless surveillance cameras. Prior to an initial public offering (IPO) on the New York Stock Exchange in August 2018, Arlo was a brand of such products by Netgear, which retained majority control after the IPO.
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
ARLO vs IRTC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $141.3M | $208.9M |
| Net Profit | $5.8M | $5.6M |
| Gross Margin | 46.4% | 70.9% |
| Operating Margin | 3.3% | 1.1% |
| Net Margin | 4.1% | 2.7% |
| Revenue YoY | 16.2% | 27.1% |
| Net Profit YoY | 218.6% | 518.5% |
| EPS (diluted) | $0.06 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $141.3M | $208.9M | ||
| Q3 25 | $139.5M | $192.9M | ||
| Q2 25 | $129.4M | $186.7M | ||
| Q1 25 | $119.1M | $158.7M | ||
| Q4 24 | $121.6M | $164.3M | ||
| Q3 24 | $137.7M | $147.5M | ||
| Q2 24 | $127.4M | $148.0M | ||
| Q1 24 | $124.2M | $131.9M |
| Q4 25 | $5.8M | $5.6M | ||
| Q3 25 | $6.9M | $-5.2M | ||
| Q2 25 | $3.1M | $-14.2M | ||
| Q1 25 | $-835.0K | $-30.7M | ||
| Q4 24 | $-4.9M | $-1.3M | ||
| Q3 24 | $-4.4M | $-46.2M | ||
| Q2 24 | $-11.6M | $-20.1M | ||
| Q1 24 | $-9.6M | $-45.7M |
| Q4 25 | 46.4% | 70.9% | ||
| Q3 25 | 40.5% | 71.1% | ||
| Q2 25 | 44.9% | 71.2% | ||
| Q1 25 | 44.3% | 68.8% | ||
| Q4 24 | 36.9% | 70.0% | ||
| Q3 24 | 35.2% | 68.8% | ||
| Q2 24 | 36.8% | 69.9% | ||
| Q1 24 | 38.1% | 66.3% |
| Q4 25 | 3.3% | 1.1% | ||
| Q3 25 | 0.6% | -4.4% | ||
| Q2 25 | 1.5% | -10.0% | ||
| Q1 25 | -1.2% | -20.5% | ||
| Q4 24 | -5.0% | -2.5% | ||
| Q3 24 | -4.0% | -34.1% | ||
| Q2 24 | -10.0% | -15.5% | ||
| Q1 24 | -8.5% | -28.9% |
| Q4 25 | 4.1% | 2.7% | ||
| Q3 25 | 4.9% | -2.7% | ||
| Q2 25 | 2.4% | -7.6% | ||
| Q1 25 | -0.7% | -19.3% | ||
| Q4 24 | -4.0% | -0.8% | ||
| Q3 24 | -3.2% | -31.3% | ||
| Q2 24 | -9.1% | -13.6% | ||
| Q1 24 | -7.8% | -34.6% |
| Q4 25 | $0.06 | $0.18 | ||
| Q3 25 | $0.06 | $-0.16 | ||
| Q2 25 | $0.03 | $-0.44 | ||
| Q1 25 | $-0.01 | $-0.97 | ||
| Q4 24 | $-0.05 | $-0.03 | ||
| Q3 24 | $-0.04 | $-1.48 | ||
| Q2 24 | $-0.12 | $-0.65 | ||
| Q1 24 | $-0.10 | $-1.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $146.4M | $583.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $127.8M | $152.7M |
| Total Assets | $310.5M | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $146.4M | $583.8M | ||
| Q3 25 | $86.0M | $565.2M | ||
| Q2 25 | $71.2M | $545.5M | ||
| Q1 25 | $84.0M | $520.6M | ||
| Q4 24 | $82.0M | $535.6M | ||
| Q3 24 | $77.0M | $522.0M | ||
| Q2 24 | $62.9M | $561.5M | ||
| Q1 24 | $62.1M | $569.1M |
| Q4 25 | $127.8M | $152.7M | ||
| Q3 25 | $129.2M | $121.9M | ||
| Q2 25 | $118.3M | $103.7M | ||
| Q1 25 | $103.4M | $86.7M | ||
| Q4 24 | $100.9M | $90.9M | ||
| Q3 24 | $96.9M | $71.8M | ||
| Q2 24 | $99.3M | $99.2M | ||
| Q1 24 | $99.9M | $90.3M |
| Q4 25 | $310.5M | $1.0B | ||
| Q3 25 | $350.9M | $995.2M | ||
| Q2 25 | $319.7M | $964.0M | ||
| Q1 25 | $296.6M | $926.1M | ||
| Q4 24 | $298.4M | $931.4M | ||
| Q3 24 | $312.4M | $909.7M | ||
| Q2 24 | $295.8M | $919.2M | ||
| Q1 24 | $289.8M | $909.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $19.8M | $26.2M |
| Free Cash FlowOCF − Capex | — | $14.5M |
| FCF MarginFCF / Revenue | — | 6.9% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | 3.43× | 4.70× |
| TTM Free Cash FlowTrailing 4 quarters | — | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $26.2M | ||
| Q3 25 | $19.2M | $34.9M | ||
| Q2 25 | $8.8M | $27.7M | ||
| Q1 25 | $30.9M | $-7.9M | ||
| Q4 24 | $6.7M | $19.2M | ||
| Q3 24 | $18.4M | $24.3M | ||
| Q2 24 | $6.5M | $11.8M | ||
| Q1 24 | $19.8M | $-52.0M |
| Q4 25 | — | $14.5M | ||
| Q3 25 | — | $20.1M | ||
| Q2 25 | — | $17.3M | ||
| Q1 25 | $28.1M | $-17.3M | ||
| Q4 24 | $5.6M | $12.4M | ||
| Q3 24 | $17.4M | $15.5M | ||
| Q2 24 | $6.2M | $3.4M | ||
| Q1 24 | $19.4M | $-61.8M |
| Q4 25 | — | 6.9% | ||
| Q3 25 | — | 10.4% | ||
| Q2 25 | — | 9.3% | ||
| Q1 25 | 23.6% | -10.9% | ||
| Q4 24 | 4.6% | 7.5% | ||
| Q3 24 | 12.6% | 10.5% | ||
| Q2 24 | 4.8% | 2.3% | ||
| Q1 24 | 15.7% | -46.8% |
| Q4 25 | — | 5.6% | ||
| Q3 25 | — | 7.7% | ||
| Q2 25 | — | 5.6% | ||
| Q1 25 | 2.4% | 5.9% | ||
| Q4 24 | 0.9% | 4.2% | ||
| Q3 24 | 0.7% | 6.0% | ||
| Q2 24 | 0.2% | 5.7% | ||
| Q1 24 | 0.3% | 7.4% |
| Q4 25 | 3.43× | 4.70× | ||
| Q3 25 | 2.79× | — | ||
| Q2 25 | 2.83× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ARLO
| Subscriptions And Services | $89.4M | 63% |
| Products | $51.9M | 37% |
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
